Abstract:
Malicious message detection and processing systems and methods are provided herein. According to some embodiments, the messages are emails and the method for processing emails may be facilitated by way of an intermediary node which may be cloud-based. The intermediary node may be communicatively couplable with an email client and an email server. The intermediary node may execute a method that includes analyzing a link included in an email to determine if the link is associated with a potentially malicious resource, and replacing the link with an alternate link to a trusted resource if the link is associated with a potentially malicious resource.
Abstract:
In one embodiment, the methods and apparatuses detect a plurality of targets; select one of the plurality of targets as a selected target; detect a profile associated with the selected target; and display information associated with the selected target, wherein the information is referenced in the profile associated with the selected target.
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
Abstract:
In one embodiment, the methods and apparatuses request an installation of an application; detect a user requesting the application; detect a profile associated with the user; and grant permission to install the application based on an installation permission.
Abstract:
In one embodiment, the methods and apparatuses request an application; detect a user requesting the application; detect a profile associated with the user; and grant permission to access the application based on an access parameter.
Abstract:
In one embodiment, a first application detects a user's activity. Based on the user's activity detected by the first application, a type of user status is determined from among a plurality of different types of possible user status. One or more features are determined of a feature set of a second application that correspond to the type of user status detected by the first application. The corresponding one or more features of the feature set of the second application are limited to prevent the one or more features from interrupting the user's activity. One or more other features of the feature set of the second application that do not correspond to the type of user status detected by the first application are permitted.
Abstract:
In one embodiment, one or more applications may be executed on a computer, where each application has an associated feature set. A user status of a particular application may be determined, and in response to that user status for the particular application, the feature set of at least one other application may be dynamically adjusted.
Abstract:
A computer system and related display techniques are presented here. The system generates and provides a graphical user interface (GUI) control element to enable user adjustment of sales forecast data, and provides a hover box associated with the GUI control element, the hover box graphically indicating adjustment status information for the sales forecast data. The system also provides a forecast table panel in the GUI. In response to receiving a request corresponding to selected forecast data included in the forecast table panel, the system generates an opportunities list panel in the GUI. The opportunities list panel includes a listing of individual opportunities and related status corresponding to the selected forecast data.
Abstract:
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Abstract:
The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.